Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity ; day:11 ; month:10 ; year:2021 ; extent:1
ChemistryOpen ; (11.10.2021) (gesamt 1)
- Creator
-
Pinzi, Luca
Foschi, Francesca
Christodoulou, Michael S.
Passarella, Daniele
Rastelli, Giulio
- DOI
-
10.1002/open.202100131
- URN
-
urn:nbn:de:101:1-2021101115234506089837
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pinzi, Luca
- Foschi, Francesca
- Christodoulou, Michael S.
- Passarella, Daniele
- Rastelli, Giulio
Other Objects (12)
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
B-Raf and the inhibitors: from bench to bedside
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
The Role of Raf-1 and B-Raf in B cell activation, differentiation, and tumorigenesis in mice
B-Raf regulation by the dimer interface and activation loop phosphorylation
The mechanism of activation of MEK1 by B-Raf and KSR1
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
B-Raf specific antibody responses in melanoma patients
The role of the Β-Raf activation loop in development and cancer
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
B-Raf and the inhibitors: from bench to bedside
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
The Role of Raf-1 and B-Raf in B cell activation, differentiation, and tumorigenesis in mice
B-Raf regulation by the dimer interface and activation loop phosphorylation
The mechanism of activation of MEK1 by B-Raf and KSR1
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
B-Raf specific antibody responses in melanoma patients
The role of the Β-Raf activation loop in development and cancer
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
B-Raf and the inhibitors: from bench to bedside
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
The Role of Raf-1 and B-Raf in B cell activation, differentiation, and tumorigenesis in mice
B-Raf regulation by the dimer interface and activation loop phosphorylation
The mechanism of activation of MEK1 by B-Raf and KSR1
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
B-Raf specific antibody responses in melanoma patients